Schedule 13G ownership disclosure

NOVOCURE LTD ORD SHS

Common Stock · CUSIP: G6674U108

Event date: 2025-09-30

Filing-level shares
2,000,000.00
Percent of class
1.8%
  • Capital World Investors

    Shares: 2,000,000.00 · Class: 1.8%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422849-25-000073
Form type
SCHEDULE 13G/A
Filer
Capital World Investors
CIK
CIK 1422849
Filed
Nov 13, 2025
Reporting period
Sep 30, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub